Search
Enter keywords, a title or a report id number below.
Your Search for 'Emerging Generic Drug Markets in Europe' returned 421 results - Page 1 of 22
Sort by
Sorted by
Rank
Top-Bottom
-
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
GBI Research, May 2011 , Pages: 69Case Study 41 6.5.2 Example of Paragraph IV Challenge That Did Not Work Out for a Generic 42 6.6 Expansion to Pharmerging Markets – Opportunities in BRIC Countries 43 6.6.1 Emerging Markets Pose an ... -
Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
Transparency Market Research, Mar 2013 , Pages: 104-absorbable stents and intraocular drug delivery implants. The market for all these product segments is provided in this report for four major geographic regions namely North America, Europe, Asia and the rest ... -
Generic Pharmaceuticals Market – A Global Analysis
Frost & Sullivan, Dec 2011 , Pages: 213the same time, the balance in terms of healthcare expenditure and sales revenue is poised to shift from developed to emerging markets such as India, China, Brazil, Russia, Turkey and South Korea, as ... -
Orphan Drug Markets in Europe: Key Developments and the Strategies of Major Pharmaceutical Companies
Spectra Intelligence, Nov 2011 , Pages: 66Orphan Drug Markets in Europe: Key Developments and the Strategies of Major Pharmaceutical Companies The successful introduction of orphan products in Europe remains problematic for the developers ... -
Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform Plans Forecast to Slow Growth Rates
GBI Research, Feb 2012 , Pages: 79(%), 2010 Figure 3: Emerging Pharmaceutical Market - Czech Republic, Branded versus Generic Share in Terms of Value(%), 2010 Figure 4: Emerging Pharmaceutical Market - Czech Republic, Government Budget ... -
Hypertension (Event Driven)
Decision Resources, Inc, Oct 2011 , Pages: 160antagonist (AIIRA) to lose patent exclusivity, in 2010. Will the launch of generic losartan alter the dynamics of AIIRA use? How will the genericization of the AIIRA class affect prescribing of other drug ... -
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Kelly Scientific Publications, May 2013 , Pages: 105propelling the biopharmaceutical market in China. It examines the current economic climate and how China compares to other emerging markets and also evolved markets such as the US and Europe. Current ... -
The Future of the Generics Industry: Opportunities, Threats and Key Trends
Scripp Business Insights, Aug 2010 , Pages: 160emerging generic markets; while new players – including multinationals – have begun to pursue footholds in the generics sector. Demand for generics will continue to increase rapidly during the next five ... -
PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
Cambridge Healthtech Institute, Jun 2012and other international R&D data from key markets - International statistics on drug development output - And much more! Plus, NEW in the 2012/2013 edition: - An all-new 2012 analysis on the ... -
Global Generics
Cygnus Research, Aug 2011 , Pages: 153. However bio-equivalence to the original brand drug has to be proved. In Europe, generic drugs are approved by the European Medicines Agency (EMEA). In Japan, Pharmaceutical and Medical Devices Agency (PMDA ... -
Intellectual Property Protection and Regulatory Regimes in Emerging Markets
Scripp Business Insights, Dec 2010 , Pages: 102to prepare for the impact of generic competition in emerging markets. - Evaluate which countries enforce intellectual property rights most effectively. - Identify in which countries your products ... -
The World Generic Market Report 2012
Espicom Business Intelligence Ltd, Mar 2012 , Pages: 552The World Generic Market Report 2012 A complete global analysis of the prospects for markets and companies in this dynamic industry sector Features and benefits of this thoroughly-researched and ... -
Pharmaceuticals - Global Outlook
Global Industry Analysts, Inc, Jan 2012 , Pages: 443briefly discusses the pharmaceutical market outlook across various markets worldwide. Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South ... -
China Pharmaceutical Market Outlook - Government Incentives, Healthcare Reform and a Rapidly Ageing Population Provide Strong Stimulus for Growth
GBI Research, Feb 2013 , Pages: 65proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. China is currently one of the most important markets in the pharmaceutical industry. It ... -
Europe Pharmaceutical & Healthcare Reports
Espicom Business Intelligence Ltd, Feb 20132013. Consequently, Hungarian drug makers will have to become even more export orientated. Russia The Russian pharmaceutical market remains a powerhouse in the Emerging Europe region . The country has ... -
Addiction Disorders
Decision Resources, Inc, Dec 2011 , Pages: 241, and Drug-Treated Prevalent Cases of Nicotine Addiction in the Major Pharmaceutical Markets, 2010-2020 Table 2-6 Number of Total, Diagnosed, and Drug-Treated Prevalent Cases of Alcohol Addiction in the ... -
Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms (Event Driven)
Decision Resources, Inc, Nov 2012 , Pages: 156or older in the major pharmaceutical markets we cover (United States, France, Germany, Italy, Spain, United Kingdom, and Japan). Demographic trends suggest an increase in the prevalent LUTS and BPH ... -
Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
GBI Research, Jun 2012 , Pages: 88factors for the emerging biosimilar industry and the regulatory environment in emerging markets with respect to biosimilars. At the end, the report provides an analysis on major deals that have taken place ... -
Renal Cell Carcinoma (Event Driven)
Decision Resources, Inc, Nov 2012 , Pages: 164Carcinoma in the Major Pharmaceutical Markets by Stage at Diagnosis, 2010-2020 Table 2-2 . Drug-Treatable Renal Cell Carcinoma Populations, by Stage, 2010-2020 Table 2-3 . Key Sources for Renal Cell ... -
Human Immunodeficiency Virus (HIV) (Event Driven)
Decision Resources, Inc, Dec 2011 , Pages: 1851-3 Key Challenges in HIV Treatment and Implications for Drug Development Table 2-1 Number of Diagnosed Incident Cases of HIV in the Major Pharmaceutical Markets, 2010-2020 Table 2-2 Number of ...
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
